This joint resolution nullifies the rule issued October 24, 2018, that lessens requirements for states to obtain waivers from certain requirements of the Patient Protection and Affordable Care Act.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 74 Introduced in House (IH)]
<DOC>
116th CONGRESS
1st Session
H. J. RES. 74
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Secretary of the
Treasury and the Secretary of Health and Human Services relating to
``State Relief and Empowerment Waivers''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
August 2, 2019
Ms. Kuster of New Hampshire (for herself, Ms. Schakowsky, Ms. Blunt
Rochester, Mr. Tonko, Ms. Barragan, Ms. Matsui, Mr. Schrader, Ms.
Mucarsel-Powell, Mr. Cardenas, Ms. Norton, Mr. Rush, Mr. Cooper, Mr.
O'Halleran, Ms. Wild, Mr. Suozzi, Mr. Welch, Mr. McNerney, Mrs.
Dingell, Mr. Trone, Ms. Castor of Florida, Mr. Espaillat, Mrs. Carolyn
B. Maloney of New York, Mr. Cohen, Mr. Garamendi, Mr. Pappas, and Mr.
Khanna) submitted the following joint resolution; which was referred to
the Committee on Energy and Commerce, and in addition to the Committee
on Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
JOINT RESOLUTION
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Secretary of the
Treasury and the Secretary of Health and Human Services relating to
``State Relief and Empowerment Waivers''.
Resolved by the Senate and House of Representatives of the United
States of America in Congress assembled, That Congress disapproves the
rule submitted by the Secretary of the Treasury and the Secretary of
Health and Human Services relating to ``State Relief and Empowerment
Waivers'' under section 1332 of the Patient Protection and Affordable
Care Act (issued October 24, 2018, as a guidance and printed at 83 Fed.
Reg. 53575, and a letter of opinion from the Government Accountability
Office dated July 15, 2019, printed in the Congressional Record on July
17, 2019, on pages S4901-S4903, concluding that such guidance is a rule
under the Congressional Review Act), and such rule shall have no force
or effect.
<all>
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line